Hormone-sensitive prostate cancer can often be effectively managed using hormone (androgen-deprivation) therapies.
October 11, 2025
high
medical
Describes a characteristic of hormone-sensitive prostate cancer and its responsiveness to hormone-based treatments.
Radiation therapy is commonly used alongside hormone therapy as part of a treatment regimen for prostate cancer.
October 11, 2025
high
medical
Describes a common clinical combination of modalities for treating prostate cancer.
Radiation therapy and hormone therapy can be components of treatment plans for prostate cancer.
high
medical
General treatment modalities for prostate cancer.
Radiation therapy and hormone therapy are established treatment modalities used to treat prostate cancer.
high
medical
General description of common therapeutic approaches for prostate cancer.
Men with metastatic prostate cancer that has spread to the bones can live for several years according to oncology experts.
high
prognosis
General prognostic information about bone‑metastatic prostate cancer.
The Gleason score is a prostate cancer grading system in which lower scores indicate cancer cells that more closely resemble normal cells; a Gleason score of 9 corresponds to Grade Group 5 and indicates a highly aggressive prostate cancer.
high
medical-definition
Clinical grading system used to describe prostate cancer aggressiveness.
The Cleveland Clinic states that prostate cancer is the second-most common cancer affecting men, and that advancing age is the most common risk factor for prostate cancer.
high
epidemiology
Prevalence and primary risk factor for prostate cancer.
Common treatment modalities for prostate cancer include radiation therapy, chemotherapy, surgery, and hormone therapy.
high
treatment
Typical classes of medical interventions used to treat prostate cancer.